SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-22-000061
Filing Date
2022-11-22
Accepted
2022-11-22 12:49:23
Documents
19
Period of Report
2022-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20221118x8k.htm   iXBRL 8-K 106656
2 EX-5.1 sava-20221118xex5_1.htm EX-5.1 16124
3 EX-10.1 sava-20221118xex10_1.htm EX-10.1 249491
4 EX-99.1 sava-20221118xex99_1.htm EX-99.1 22780
5 EX-99.2 sava-20221118xex99_2.htm EX-99.2 23406
6 GRAPHIC sava-20221118xex5_1g001.jpg GRAPHIC 2674
7 GRAPHIC sava-20221118xex99_1g001.jpg GRAPHIC 15020
8 GRAPHIC sava-20221118xex99_2g001.jpg GRAPHIC 15020
  Complete submission text file 0001069530-22-000061.txt   654561

Data Files

Seq Description Document Type Size
9 EX-101.SCH sava-20221118.xsd EX-101.SCH 2660
10 EX-101.LAB sava-20221118_lab.xml EX-101.LAB 15228
11 EX-101.PRE sava-20221118_pre.xml EX-101.PRE 10845
13 EXTRACTED XBRL INSTANCE DOCUMENT sava-20221118x8k_htm.xml XML 4875
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 221409111
SIC: 2834 Pharmaceutical Preparations